Welcome to our dedicated page for BioSig Technologies news (Ticker: BSGM), a resource for investors and traders seeking the latest updates and insights on BioSig Technologies stock.
BioSig Technologies, Inc. completed its transition to Streamex Corp. after merging with Streamex Exchange Corporation and changing its Nasdaq ticker to STEX. Company news now centers on Streamex’s real-world-asset and gold tokenization business, including institutional-grade infrastructure for on-chain gold markets, a gold-denominated treasury strategy, and tokenized yield-bearing gold products.
Recurring updates also cover strategic partnerships, exchange-traded product concepts, public offerings, shareholder voting matters, capital-structure disclosures, and the company’s completed rebrand from a medical-device issuer associated with the PURE EP Platform to a gold tokenization and treasury-focused public company.
BioSig Technologies, Inc. announced new appointments to its board of directors, now fully constituted with 5 members, 3 independent. The company aims for compliance with U.S. Exchange regulations, bringing in directors with diverse industry experience to create lasting shareholder value.
BioSig Technologies, Inc. appointed Mr. Anthony Amato as the Chief Executive Officer and member of the Board of Directors to accelerate the implementation of a comprehensive turnaround strategy. Mr. Amato brings a wealth of experience in business leadership and management. The Company aims to unlock substantial value through its core product line, PURE EP™, and plans to update shareholders on further developments.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.